Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)

Clinical trial NCT05281276 · TERMINATED

Trial details

NCT number: NCT05281276
Sponsor: Taipei Medical University Shuang Ho Hospital
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2022-09-20
Primary completion: 2024-03-26
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.